Myoclonic Seizures Global Clinical Trials Review, H2, 2014

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Myoclonic Seizures Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2243632/Myoclonic-Seizures-Global-Clinical-Trials-Review-H2-2014.html

Myoclonic Seizures Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Myoclonic Seizures Global Clinical Trials Review, H2, 2014" provides data on the Myoclonic Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonic Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myoclonic Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Introduction 6
Myoclonic Seizures 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Myoclonic Seizures 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Myoclonic Seizures Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
UCB S.A. 30
Clinical Trial Overview of UCB S.A. 30
Biocodex SA 31
Clinical Trial Overview of Biocodex SA 31
Teva Pharmaceutical Industries Limited 32
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 32
Sky Growth Acquisition Corporation 33
Clinical Trial Overview of Sky Growth Acquisition Corporation 33
GW Pharmaceuticals plc 34
Clinical Trial Overview of GW Pharmaceuticals plc 34
Eisai Co., Ltd. 35
Clinical Trial Overview of Eisai Co., Ltd. 35
Desitin Arzneimittel GmbH 36
Clinical Trial Overview of Desitin Arzneimittel GmbH 36
Bluefish Pharmaceuticals AB 37
Clinical Trial Overview of Bluefish Pharmaceuticals AB 37
Adamed Sp. z o.o. 38
Clinical Trial Overview of Adamed Sp. z o.o. 38
Clinical Trial Overview of Top Institutes / Government 39
National Institute of Neurological Disorders and Stroke 39
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 39
University of Colorado Denver 40
Clinical Trial Overview of University of Colorado Denver 40
Shizuoka University 41
Clinical Trial Overview of Shizuoka University 41
Institut National de la Sante et de la Recherche Medicale 42
Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 42
University of Turku 43
Clinical Trial Overview of University of Turku 43
Five Key Clinical Profiles 44
Appendix 55
Abbreviations 55
Definitions 55
Research Methodology 56
Secondary Research 56
About GlobalData 57
Contact Us 57
Disclaimer 57
Source 57


List of Tables

Myoclonic Seizures Therapeutics, Global, Clinical Trials by Region, 2014* 7
Myoclonic Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Myoclonic Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Myoclonic Seizures Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Myoclonic Seizures Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Myoclonic Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Myoclonic Seizures Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Myoclonic Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Myoclonic Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Myoclonic Seizures Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Myoclonic Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Myoclonic Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Myoclonic Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Myoclonic Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Myoclonic Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014* 30
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Biocodex SA, 2014* 31
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014* 32
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Sky Growth Acquisition Corporation, 2014* 33
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014* 34
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 35
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Desitin Arzneimittel GmbH, 2014* 36
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014* 37
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Adamed Sp. z o.o., 2014* 38
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 39
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2014* 40
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Shizuoka University, 2014* 41
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut National de la Sante et de la Recherche Medicale, 2014* 42
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Turku, 2014* 43


List of Figures

Myoclonic Seizures Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Myoclonic Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Myoclonic Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Myoclonic Seizures Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Myoclonic Seizures Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Myoclonic Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Myoclonic Seizures Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Myoclonic Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Myoclonic Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Myoclonic Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Myoclonic Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Myoclonic Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Myoclonic Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Myoclonic Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 56


Read the full report:
Myoclonic Seizures Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2243632/Myoclonic-Seizures-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer